BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Alliances
Lupin Ltd. (LUPN.BO), Merck Serono Forge Emerging Markets Pact; Deal Could Add Up To 20 Drugs To Merck's Portfolio 9/16/2014
PHARNEXT And The Hereditary Neuropathy Foundation Collaborate To Increase Awareness Of Charcot-Marie-Tooth Disease 9/16/2014
Axxess Pharma, Inc. Expands Global License Agreement With ABG TapouT To Include Several New High Demand Products 9/16/2014
JDRF And Tidepool Partner To Bring Data To An Open Source Platform For People With Type 1 Diabetes 9/16/2014
WellDoc And American Diabetes Association's Maryland Chapter Announce A New Collaboration To Empower People With Type 2 Diabetes To Manage Their Condition 9/16/2014
Cannabis Science Inc. And Unistraw Holdings Join Forces To Produce Proprietary Formulations Delivering A Wide Array Of Unique Cannabis Extracts And Pure Cannabinoid-Based Products 9/16/2014
Coldstream Laboratories Inc. Partners With CytImmune Sciences Inc. For Phase 2 Sterile Manufacturing 9/16/2014
GlaxoSmithKline (GSK) Exercises Option For Five Prime Therapeutics, Inc. (FPRX)'s Skeletal Muscle Drugs 9/16/2014
Curie-Cancer And Inventiva Announce A Partnership In Epigenetics For The Treatment Of Cancer 9/16/2014
Relmada Therapeutics Enters Into Agreement With Memorial Sloan-Kettering Cancer Center To Better Clarify Unique Mechanism Of Action For LevoCap ER 9/16/2014
Galen Signs Exclusive Deal in Europe 9/16/2014
Eli Lilly and Company (LLY) Bets $500 Million On AstraZeneca PLC (AZN)’s Alzheimer's Drug 9/16/2014
Lupin Ltd. (LUPN.BO) May Sign $1.5 Billion Deal With Merck Serono; Lupin Stock Hits A New High 9/15/2014
Gilead Sciences, Inc. (GILD) Says Indian Firms May Sell Generics of Hep C Drug Sovaldi 9/15/2014
Google Inc.-Backed Calico Announces Plan To Combat ALS, Parkinson's 9/15/2014
Cellprothera® And BioCardia Partner On Phase 2 EXCELLENT Trial 9/15/2014
Advanced Biological Laboratories SA (ABL) Enters Promotional Agreement With Abbott Laboratories (ABT) For Innovative Software Suite In HIV Genotyping 9/15/2014
HUYA Bioscience International And TIPR Announce Joint Venture To Develop Medical Innovation For Global Markets 9/15/2014
BeiGene Co.,Ltd Receives Clinical Milestone Payment For Development Of BGB-290 9/15/2014
NantBioscience And University of Colorado To Collaborate On Development Of Novel Protein Cancer Fighting Drugs 9/15/2014
Evotec AG (EVTG.F) And The Jain Foundation Expand Collaboration: Start Of Multiple Drug Screening Programmes 9/15/2014
Mylan Inc. (MYL) Signs Agreement With Gilead Sciences, Inc. (GILD) To Accelerate Access To Hepatitis C Treatments, Sovaldi® (Sofosbuvir) And Single Tablet Regimen Of Ledipasvir/Sofosbuvir, in Developing Countries 9/15/2014
BioHealth Innovation Signs Agreement With Roche (RHHBY) To Source Technologies For Research, Development And Commercialization 9/15/2014
Internet Scientific Publications Partners With UBM Medica US 9/15/2014
Simulations Plus (SLP) Wins Cooperative Agreement With FDA 9/15/2014
Dad Turned Biotech CEO Inks Drug Testing Deal With Pfizer (PFE) 9/12/2014
BGI And The Vancouver Prostate Centre Announce Partnership To Create Joint Research Laboratory For Advancement Of Translational Cancer Research 9/12/2014
Bay Area's Cellerant Therapeutics, Inc. Awarded $47.5 Million From The U.S. Government 9/11/2014
Mimetogen Pharmaceuticals Announces Expiration Of Exclusive Option Agreement With Bausch & Lomb 9/11/2014
Evotec AG (EVTG.F) And CHDI, Inc. Foundation Extend Ongoing Collaboration To Fight Huntington's Disease 9/11/2014
ChromaDex, Inc. And Healthy Directions Enter Into NIAGEN™ Supply Agreement 9/11/2014
Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 9/11/2014
Cerus Corporation (CERS) And Biomedica Foscama Group S.P.A. Enter Distribution Agreement For The INTERCEPT Blood System In Italy 9/11/2014
Sophia Genetics Announces First Deal With Britain's NHS And Leading Turkish Laboratory, Expanding European Customer Base 9/11/2014
NeuroVive Pharmaceutical AB: Addendum: Oncore License 9/11/2014
BioInvent (BOVNF) Receives Another Milestone Payment From Bayer In Connection With Start Of A Phase I Trial 9/11/2014
ProPhase Labs, Inc. (Formerly Known as Quigley Corporation) (QGLY) Expects To Report A $3.6 Million Impairment Charge Relating To Its Phusion Joint Venture 9/11/2014
Medivation, Inc. (MDVN) Banks $90 Million From Astellas Pharma Inc. (ALPMY) As FDA Expands Use Of Prostate Cancer Drug 9/10/2014
Seattle Genetics, Inc. (SGEN), Genmab A/S (GEN.CO) Partner In $211 Million Antibody-Drug Pact 9/10/2014
Hemispherx Biopharma (HEB) And The Swiss Department Of Defense, Civil Protection And Sports Expand Their Collaborative Research Agreement To Include The Study Of Alferon® And Ampligen® Against The Ebola Virus 9/10/2014
MabVax Therapeutics, Inc. Enters Agreements With Memorial Sloan-Kettering Cancer Center And Juno Therapeutics For Development Of Anti-Cancer Therapeutics 9/10/2014
Inocucor Technologies Signs First Commercial Strategic Partnership With Axter Agroscience 9/10/2014
Sectra (SECTB) Joins HIMSS Innovation Center As A Supporting Collaborator 9/10/2014
EMD Group (EMD Millipore (Massachusetts)) And Accelerated Cure Project Launch Collaborative Research Program To Optimize Treatment And Understand Progression Of Multiple Sclerosis 9/10/2014
Mettler-Toledo (MTD) Release: New Pharmaceutical Solid Dosage Form Development Collaboration 9/10/2014
Medidata Solutions, Inc. And ICON Join Forces To Bring New Productivity To Capturing Patient Voice In Clinical Trials 9/10/2014
University of Minnesota Masonic Cancer Center Joins CEL-SCI (CVM)’s Phase 3 Head & Neck Cancer Trial 9/10/2014
Trialbee Helps AstraZeneca PLC (AZN) Reduce The Time Required For Recruitment Of Patients To Clinical Trials 9/10/2014
PharmAthene, Inc. (PIP) Awarded Contract Of Up To $28.1 Million To Develop Next Generation Thermostable Anthrax Vaccine 9/10/2014
Shenzhen Beike Biotechnology Co. Ltd., Altor BioScience Corporation Strike $200 Million Cancer Deal 9/10/2014
XenoPort, Inc. (XNPT) And The NIAAA Announce Clinical Trial Agreement To Study HORIZANT As A Potential Treatment For Alcohol Use Disorder 9/9/2014
NeuroVive Pharmaceutical AB, Oncore Sign $150 Million Hepatitis B Pact 9/9/2014
Relypsa, Inc. (RLYP) Announces Commercial Manufacturing Agreement With Patheon Inc. (PTI.TO) 9/9/2014
Oncore Licenses Second-Generation Cyclophilin Inhibitors From Neurovive For The Treatment Of Chronic HBV Infection 9/9/2014
genae Opens Offices In Dubai And Announces Collaboration With Leading Gulf Clinicians 9/9/2014
Sutro Biopharma To Collaborate With University of California, San Francisco (UCSF), A Recombinant Antibody Network (RAN) Member 9/9/2014
Ligand Pharmaceuticals Inc. (LGND) Licenses Captisol-Enabled™ Lamotrigine To CURx Pharmaceuticals 9/9/2014
SRI International And Nobelpharma, Partner On Endometriosis Drug Development 9/9/2014
Mayo Clinic And Delos®, The Pioneer Of Wellness Real Estate™, Announce Agreement To Establish The WELL Living Lab 9/9/2014
Emergent BioSolutions (EBS) Awarded $29 Million Contract To Develop A Dry Formulation Of Nuthrax 9/9/2014
Cempra Pharmaceuticals, Inc. Gets $10 Million Milestone Payment From Toyama Chemical Company 9/9/2014
Google Inc.'s Startup Calico Forges Pact With AbbVie (ABBV), New R&D Facility In San Francisco 9/9/2014
Ophthotech Corporation (OPHT) Banks $50 Million Milestone From Novartis AG (NVS) For Fovista® Pact 9/8/2014
Schrödinger And Tri-Institutional Therapeutics Discovery Institute Announce Agreement To Provide Drug Discovery Software To Tri-Institutional Researchers 9/8/2014
Lee's Pharm In-licenses Second Product From Italy's Abiogen Pharma 9/8/2014
Emergent BioSolutions (EBS) Awarded Contract To Develop A Dry Formulation Of Nuthrax, A Next Generation Anthrax Vaccine 9/8/2014
Venus Remedies Ties It Up With Mylan Inc. (MYL) For Marketing Meropenem In Three European Countries 9/8/2014
Janssen Pharmaceutical Inc. And Johnson & Johnson (JNJ) Innovation Establish Research Collaboration With The University of Toronto 9/8/2014
Innovus Pharma Expands US Distribution By Signing A Non-Exclusive Sampling And Distribution Agreement With Bulu Box® For Zestra® In The U.S. 9/8/2014
Hemispherx Biopharma (HEB) And United States Army Medical Research Institute Of Infectious Diseases (USAMRIID) Agree To Collaborate In Studying Alferon® And Ampligen® Against The Ebola Virus 9/8/2014
Zhejiang Huahai And Tianjin Pharma To Form U.S.-Aimed Partnership 9/8/2014
PeriGen Announces Partnership With University Of Utah Hospital For PeriCALM Evidence-based Fetal Strip Interpretation 9/8/2014
PharmAthene, Inc. (PIP) And Nanotherapeutics Form Strategic Alliance To Advance Biodefense Programs 9/8/2014
Pharmatech, Inc. Announces Research Collaboration Under Phase II National Cancer Institute/SBIR Grant With Weill Cornell Medical College 9/8/2014
Mayo Clinic And IBM Task Watson To Improve Clinical Trial Research 9/8/2014
University of Toronto Announces Strategic Collaboration With Janssen Inc. And Johnson & Johnson Innovation (JNJ) 9/8/2014
Almac Group Forms Academia-Industry Collaboration To Develop Green Chemicals 9/8/2014
Solentim Ltd Embraces CRISPR And Other Rapid Gene-Editing Technologies With Horizon Discovery Ltd. 9/8/2014
PharmAthene, Inc. (PIP) And Nanotherapeutics Form Strategic Alliance To Advance Biodefense Programs 9/8/2014
Gilead Sciences, Inc. (GILD) Close To Inking Deal That Would Bring Low-Cost Versions Of $84,000 Solvadi Drug To Poor Countries 9/5/2014
AbbVie (ABBV) Hands Over $275 Million Upfront For Infinity Pharmaceuticals Inc. (INFI)’s Blood Cancer Drug; Deal Could Be Worth $805 Million 9/5/2014
Pfizer Inc. (PFE) Strikes Pact To Market Novartis AG (NVS)'s Respiratory Inhalers In The UK 9/5/2014
Earlier Tumour Diagnosis With Advanced Ultrasound Technology From Oxford University 9/5/2014
Hainan Sinotau In-Licenses Radiopharmaceutical From Navidea Biopharmaceuticals (NAVB) Of The U.S. 9/5/2014
Tiny Redx Pharma Signs "Transformational" Cancer Deal With AstraZeneca PLC (AZN); Financial Terms Have Not Been Disclosed 9/4/2014
Metabolon And Baylor College of Medicine Partner To Launch Global Metabolomic-Assisted Pathway Screen (MAPS) For Inborn Errors Of Metabolism 9/4/2014
Bavarian Nordic (BAVA.CO) Accelerates Ebola Vaccine Development Programs In Collaboration With The National Institutes of Health (NIH) 9/4/2014
Abcam plc (ABC.L) And Cell Marque Sign Global Strategic Marketing Agreement For IVD IHC RabMAb Antibodies 9/4/2014
Masters Speciality Pharma Enters Agreement With ApoPharma 9/4/2014
Navidea Biopharmaceuticals (NAVB) Enters Lymphoseek® Development And Commercialization Agreement For China 9/4/2014
SELLAS Life Sciences Group Signs Exclusive License Agreement For Global Rights On Development And Commercialization Of WT1 Cancer Vaccine With Memorial Sloan-Kettering Cancer Center 9/4/2014
Vectura Group plc (VEC.L) Release: Announcement Of Commercial Arrangement With Pfizer Inc. (PFE) UK To Promote Ultibro® Breezhaler® And Seebri® Breezhaler® In The United Kingdom 9/4/2014
Shionogi & Co., Ltd. Enlists BuzzeoPDMA, A Cegedim Company To Support Their Sample Management Compliance Programs 9/4/2014
BeiGene Co.,Ltd Signs China CMO Deal With Boehringer Ingelheim Corporation 9/4/2014
Zoetis (ZTS) Granted Conditional License For Porcine Epidemic Diarrhea Vaccine* 9/3/2014
Palatin Technologies (PTN) Licenses Bremelanotide In Europe And Other Selected Countries To Gedeon Richter Ltd. (RIG2.F) 9/3/2014
CMC Biologics And Zymeworks Enter Into Agreement For Process Development And Clinical Manufacture Of Bi-Specific Antibody Product Candidate 9/3/2014
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives $1 Million Pursuant To Product License And Stock Purchase Agreement 9/3/2014
Infinity Pharmaceuticals Inc. (INFI) Enters Into Master Clinical Supply Agreement And Material Transfer Agreement With Roche (RHHBY) 9/3/2014
Rosetta Genomics Ltd. (ROSG) And H. Lee Moffitt Cancer Center & Research Institute Enter Into Strategic Alliance To Develop microRNA-Based Cancer Diagnostics 9/3/2014
Bristol-Myers Squibb Company (BMY) Gives Back Rights To Alder Biopharmaceuticals Inc.'s Promising Arthritis Drug Clazakizumab 9/2/2014
Ablynx (ABLYF) Signs Exclusive License Agreement With Eddingpharm (Cayman) Inc. To Develop And Commercialise Its Anti-Tnfa Nanobody In Greater China 9/2/2014
Amarillo Biosciences (AMAR) Initiates CLIA Development Of Alzheimer's Blood Diagnostic Lympro Test® At ICON Central Laboratories 9/2/2014
Chimerix, Inc. (CMRX) And Biomedical Advanced Research and Development Authority (BARDA) Announce Continued Partnership In The Development Of Brincidofovir For Smallpox 9/2/2014
Advanced Biological Laboratories SA (ABL) And Mayo Medical Laboratories Announce Collaboration And Licensing Agreements 9/2/2014
EMD Group (EMD Millipore Headquarters) And Massachusetts General Hospital Collaborate To Better Understand Systemic Lupus Erythematosus And Lupus Nephritis 9/2/2014
Intrexon Corporation Announces Exclusive Channel Collaboration With Sanofi (France) (SAN.PA) To Optimize Production For A Specific Family Of Active Pharmaceutical Ingredients 9/2/2014
CleveXel Pharma Partners With Guilin Pharmaceutical To Develop Two New Anti-Malarial Products 9/2/2014
Minomic: Collaboration With U.S. Partner For New Prostate Cancer Treatment 8/29/2014
22nd Century Group, Inc. Partner NASCO Products Enters Into Agreement With Smoker Friendly International 8/29/2014
Innovus Pharma Signs Exclusive Marketing And Distribution Agreement With Danalife Aps To Market And Distribute Zestra® For Alternative Markets 8/28/2014
Formal Transfer Of Global Rights For Tozadenant To BioTie Therapies Corp. Concluded 8/28/2014
BioTime (BTX) To Collaborate With The University of Wisconsin And Louvain University In Test Of Hystem®-Based Hydrogel For Vocal Fold Scarring 8/28/2014
Dow Microbial Control Forges Commercial Agreement With Xgenex For U.S. Sales Of Dow AOS Certified Technology 8/28/2014
Mafraq Hospital Improves Diabetic Care After University Collaboration 8/28/2014
United States Department Of Commerce Partners With Virocyt To Expand Asian Markets 8/28/2014
Atossa Genetics, Inc. (ATOS) Announces Commercial Partner for Laboratory Services Offered By The National Reference Laboratory For Breast Health, Inc. 8/28/2014
Amerigen Pharmaceuticals And The Ningbo MENOVO Pharmaceutical Co.,LTD., Today Announced They Had Entered Into A Collaboration Agreement Regarding The Development Of Generic Pharmaceuticals, Primarily Targeting The United States Market 8/27/2014
LabSmith, Inc. Products Now Distributed In South Korea By Revodix, Inc. 8/27/2014
Drug Giants Merck & Co. (MRK) And Pfizer (PFE) Forge Cancer Pact 8/27/2014
Tiny Biotech Advaxis, Inc. Inks Another Pact With Merck & Co. (MRK) To Test Immune Therapies Against Prostate Cancer 8/26/2014
Bavarian Nordic (BAVA.CO) Receives Order From The Canadian Government To Supply IMVAMUNE® Smallpox Vaccine 8/26/2014
A*STAR, BCA And Hitachi, Ltd. (HIT) Pilot Plant Facilitates Research For Greener Buildings 8/26/2014
MRC Technology Negotiates License With Bio-Techne For MRC’s GOPAL Protein Synthesis Technology 8/26/2014
Concert Pharmaceuticals, Inc. (CNCE) Achieves $2 Million Milestone For AVP-786 Under AVANIR Pharmaceuticals (AVNR) Collaboration 8/26/2014
AB SCIEX And Dalton Pharma Services Collaborate To Advance Antibody-Drug Conjugate Analysis 8/26/2014
iBio, Inc. (IBIO) Enters Into $10 Million Common Stock Purchase Agreement With Aspire Capital 8/26/2014
Novozymes A/S (NVZMY) And Monsanto Company (MON) Showcase New Ag Innovations Expected To Increase Sustainability On The Farm 8/26/2014
Anavex Life Sciences Corp. (AVXL.OB) Selects The Alfred Hospital In Melbourne, Australia As Lead Site For Phase 2a Alzheimer's Clinical Trial 8/26/2014
Viropro Inc. (VPRO) Initiates Interim Debt Financing Of Up To $500,000 8/26/2014
ViveBio And Laboratory Procurement Services Sign Agreement For Distribution Of The ViveST Line Of Products 8/26/2014
Recipharm AB Forms New Collaboration With Isofol Medical AB To Exclusively Manufacture Modufolin® And Invests SEK 8 Million In The Company 8/26/2014
Cardiome Pharma Corp. (COM.TO) Enters Commercialization Agreement With Eurolab Especialidades Medicinales For Brinavess™ In Argentina 8/25/2014
Tauriga Sciences Inc. (TAUG) Executes Investment Banking Agreement With Tokyo, Japan Based Dragoon Capital Inc. 8/25/2014
Telik, Inc. (TELK) Receives $1.5 Million National Cancer Institute Contract To Develop Novel Antibody-Based PET Imaging Agent For Pancreatic Cancer 8/25/2014
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Gains $20 Million Through Deal With Janssen Research & Development 8/22/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Announces New Exclusive Global Manufacturing And Supply Agreement For Lubiprostone 8/22/2014
Luye In-Licenses China Rights To Cancer Drug From Korea's Hanmi Pharmaceutical, Co., Ltd 8/22/2014
DESY And IBM Corporation (IBM) Develop Big Data Architecture For Science 8/21/2014
Gallus Biopharmaceuticals, LLC Enters Agreement With Progenics Pharmaceuticals, Inc. (PGNX) For Manufacture Of Anti-PSMA Monoclonal Antibody 8/21/2014
Sarepta Therapeutics (SRPT) Enters Into Partnership With Flagship Biosciences LLC To Digitally Automate The Measurement Of Dystrophin, A Key Therapeutic Efficacy Marker For Muscular Dystrophy 8/21/2014
Antitope And University College London Enter Into A Research & Licence Agreement For The Generation Of Fully Humanized Antibodies Using Antitope’s Composite Human Antibody™ Technology 8/21/2014
Vensun Pharmaceuticals Enters Into Manufacturing, Supply and Distribution Agreement With ScieGen Pharmaceuticals, Inc. 8/21/2014
Massachusetts Biotechnology Council, Inc. Announces New Collaborations With Nature Publishing Group & Journal Of Commercial Biotechnology 8/21/2014
New Amsterdam Sciences Continues Pact With Dr. Jacob Finkelstein, PhD To Advance Pulmonary Fibrosis Research 8/21/2014
Angiocrine Bioscience Licenses New Stem Cell Technology From Weill Cornell Medical College 8/21/2014
Illumina, Inc. (ILMN) Partners With AstraZeneca PLC (AZN), Johnson & Johnson (JNJ) To Create New Genetic Tests For Cancer 8/21/2014
AstraZeneca PLC (AZN), Mitsubishi Tanabe Pharma Corporation Link Up For Diabetes Research 8/20/2014
Emergent BioSolutions (EBS), MorphoSys AG Strike Prostate Cancer Pact Worth $183 Million 8/20/2014
Novartis AG (NVS), Global Alliance For TB Drug Development Link Up To Search For TB Cure 8/20/2014
Crohn's and Colitis Foundation of America Release: Expanding IBD Research Through Collaboration 8/20/2014
Bristol-Myers Squibb Company (BMY) And Celgene (CELG) Enter Clinical Collaboration Agreement To Evaluate Immunotherapy And Chemotherapy Combination Regimen 8/20/2014
Global Institute Of Forensic Research Contracts With The Council Of State Governments To Provide Executive Bulletin Service 8/20/2014
Igenbio, Inc. And Genome Compiler Corp. Enter Into A Collaborative Agreement To Offer Synthetic Biology Solutions 8/20/2014
Evotec AG (EVTG.F) And Medicines for Malaria Venture (MMV) Announce A Long-Term Compound Management Collaboration 8/19/2014
A*STAR And Sumitomo Mitsui Banking Corporation Ink MOU To Support Japanese R&D Collaborations With Singapore 8/19/2014
CAPSUGEL And Cardax Pharmaceuticals Inc. To Collaborate On Development Of Proprietary Astaxanthin Products 8/19/2014
Biomedical Advanced Research and Development Authority (BARDA) Extends Contract With Cytori Therapeutics, Inc. (CYTX) For Burn Treatment, Deal Is Worth Up To $20.4 Million 8/19/2014
Vectura Group plc (VEC.L) Interim Management Statement 8/19/2014
Roche (RHHBY) And Garvan Institute of Medical Research Partner To Develop Genomics Technologies For Targeted Epigenomic Analysis 8/19/2014
Mount Tam Biotechnologies Awarded Worldwide Exclusive License For Research Assets From the Buck Institute -- Advancing Promising Medical Compounds For The Treatment of Lupus Towards The FDA Drug Approval Process 8/19/2014
Abbott Laboratories (ABT) Strikes $20 Million Pentagon Deal For Brain Injury Device 8/18/2014
Provectus Biopharmaceuticals Inc. Signs Memorandum Of Understanding With Sinopharm-China State Institute Of Pharmaceutical Industry, And Sinopharm A-THINK Pharmaceutical Co., Ltd. 8/18/2014
HUYA Bioscience International Announces Partnership With Changzhou Center For Biotech Development 8/18/2014
MMS Holdings, Inc. And Oncology Trials Insights Form Strategic Partnership To Deliver Comprehensive Oncology Support Services 8/18/2014
Immune Targeting Systems (ITS) Ltd. And WCCT Global Announce A New Influenza A H1N1 Virus To Support The Experimental Human Viral Challenge Model 8/18/2014
Expression Therapeutics Selects Advanced BioScience Laboratories, Inc. To Support Cell Line Development For Hemophilia A Factor VIII Infusion Therapy 8/18/2014
Pharpoint Research Wins Project Award From Otologic Pharmaceuticals 8/18/2014
ImmuDyne, Inc. (IMMD) Announces Launch Of Clinical Study 8/15/2014
Innovus Pharma And Consortia Health Initiate A Nationwide Marketing And Sales Campaign To U.S. Gynecologists For Zestra®, Clinically Proven For The Enhancement Of Female Arousal Desire And Satisfaction 8/15/2014
Amarillo Biosciences (AMAR) Exercises Option To License Intellectual Property From University Of Miami Bascom Palmer Eye Institute For Use Of MANF In Retinal Disorders 8/15/2014
Isis Pharmaceuticals, Inc. (ISIS) Earns $2 Million From The Advancement Of ISIS-SMN Rx In Children With Spinal Muscular Atrophy 8/15/2014
Ligand Pharmaceuticals Inc. (LGND) Signs Multi-Program Captisol® License Agreement With Avion Pharmaceuticals 8/14/2014
TNI BioTech Expands Partnership With Hubei Qianjiang Pharma 8/14/2014
Roche (RHHBY) Backs Out Of $600 Million Acromegaly Drug Development Deal With Chiasma Inc. 8/14/2014
RedHill Biopharma Ltd. (RDHL) Acquires Option For Phase 2 Pancreatic Cancer Drug RP101 8/13/2014
Retroscreen Virology Limited Partners With ERT For Centralised ECG Services In Hvivo Challenge Studies 8/13/2014
TNI BioTech And Hubei Qianjiang Pharmaceutical Co., Ltd Supplemental Collaborative Agreement 8/13/2014
23andMe, Inc., Pfizer Inc. (PFE) Strike Pact To Research The Genetics Of Inflammatory Bowel Disease 8/12/2014
ProSensa Holding N.V. (RNA) And CureDuchenne Strengthen Long-Term Collaboration With An Additional [Eur]5M To Advance DMD Pipeline 8/12/2014
Marinus Pharmaceuticals (MRNS) Enters Into Use Agreement With CyDex Pharmaceuticals For Use Of Captisol® For Ganaxolone IV 8/12/2014
Fred's And Cardinal Health, Inc. (CAH) Announce Primary Supply Agreement 8/12/2014
FORMA Therapeutics, Inc. And Paradigm Announce Molecular Profiling Collaboration For Drug Candidates 8/12/2014
Feist-Weiller Cancer Center Partners With Caris Life Sciences To Establish A Clinical Molecular Profiling Program 8/12/2014
Myelin Repair Foundation Announces Long-Term European Partnership With Hertie Foundation 8/12/2014
Protein Sciences Corporation And Liomont Announce Licensing Of Proprietary Influenza Vaccines For The Mexico Market 8/12/2014
ITEN And Biogenerator Work Together At Intersection Of IT And Bioscience Startups 8/12/2014
Novartis AG (NVS), GlaxoSmithKline (GSK) Reshape Pharma With Game-Changing $14.5 Billion Deal 8/12/2014
Sanofi (France) (SAN.PA) To Pay MannKind Corporation (MNKD) Up To $925 Million For Inhaled Insulin 8/12/2014
Galapagos NV (GLPG.BR), GlaxoSmithKline (GSK) Abandon Joint Drug Project Due To Adverse Effects 8/11/2014
Sigma-Tau Pharmaceuticals Signs Exclusive Agreement With Crosscare Limited For U.S. Marketing And Distribution License Of Colief® Infant Drops For The Treatment Of Colic-Associated Crying 8/11/2014
Amarantus BioSciences, Inc. Enters Into Research Collaboration With The Buck Institute for Age Research For MANF 8/11/2014
ALR Technologies Inc. To Conduct Clinical Trial With Premier Hospital Of Chilean Health Ministry In Santiago 8/11/2014
Cryoprinting Red Blood Cells: Akron Biotechnology, LLC And Stanford University Collaborative Study 8/11/2014
Radient Technologies Inc. Awarded Contract By Fortune 500 Consumer Staples Company 8/11/2014
Human Longevity Inc. And Celgene Cellular Therapeutics Sign License Agreement To Develop And Commercialize Placental Stem Cell Population, PSC-100 For Multiple Therapeutic Applications 8/11/2014
Cancer Research Technology And Cancer Research UK Cambridge Research Institute Join Forces With Astellas Pharma Inc. (ALPMY) On Autophagy To Find New Cancer Treatments 8/8/2014
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement With DinoNa For Leukotuximab 8/8/2014
U.S. Government Exercises Contract Options Valued At $18.9 Million For Emergent BioSolutions (EBS)' Vaccinia Immune Globulin Intravenous Program 8/8/2014
Eirgenix Signs Agreement With Taimed To Provide Development And Manufacturing Services For Taimed’s Second Generation anti-HIV mAb TMB-360 8/7/2014